Nuclear Radiology: Page 64

Global nuclear medicine market could reach $4.5B

By AuntMinnieEurope.com staff writers

Varied uses of new technology will drive the global nuclear medicine imaging device market to $4.5 billion by 2022, according to a new study from market research firm Companies and Markets.

July 4, 2012

PET/CT enhances assessment of pulmonary melanoma

By Philip Ward

PET cannot rule out malignancy in pulmonary nodules less than 12 mm on expiratory CT, and melanoma patients with PET-negative pulmonary nodules less than 12 mm require further investigation, a new Austrian study has found.

June 25, 2012

GE promotes DaTscan study results

By AuntMinnieEurope.com staff writers

GE Healthcare is touting the results of a randomized, controlled study that found its contrast agent DaTscan to be useful in SPECT imaging of adult patients with clinically uncertain Parkinsonian syndromes.

June 20, 2012

Numa announces molecular agreement with Siemens

By AuntMinnieEurope.com staff writers

Nuclear medicine connectivity developer Numa has entered into a compatibility agreement with Siemens Healthcare Molecular Imaging with respect to the development of a customized clinical image and data management system it has developed.

June 18, 2012

Bruker opens customer support center in Moscow

By AuntMinnieEurope.com staff writers

Scientific instrument company Bruker has opened a new applications and customer support center of excellence in Moscow.

June 17, 2012

Identifying top trends in Europe's nuclear medicine market

By Anthony Stevens, PhD

The number of diagnostic nuclear medicine procedures (excluding PET) performed in France, Germany, Italy, Spain, and the U.K. rose by about 1% a year between 2007 and 2011, and France showed the highest level of growth in terms of patient numbers.

June 17, 2012

German team collects SNM Image of the Year award

By Wayne Forrest

German researchers have received this year's Image of the Year award at the recent Society of Nuclear Medicine (SNM) annual meeting for their research illustrating the effectiveness of a new radiopharmaceutical for treating digestive tumors.

June 17, 2012

SNM: PET/CT predicts colorectal cancer outcomes

By AuntMinnieEurope.com staff writers

Careful monitoring of colorectal cancer patients with PET/CT during initial treatment can predict outcomes, potentially improving success rates while reducing treatment costs, Italian researchers reported at this week's Society of Nuclear Medicine (SNM) meeting in Miami Beach, FL.

June 11, 2012

ITG, NTP cooperate on global radioisotope production

By AuntMinnieEurope.com staff writers

ITG Isotope Technologies Garching and NTP Radioisotopes, a subsidiary of the South African Nuclear Energy Corporation, announced that they will collaborate to guarantee that Brazil and African countries will have a reliable supply of high quality radioisotopes.

June 11, 2012

SNM: New therapy extends life for prostate cancer patients

By AuntMinnieEurope.com staff writers

Survival is bleak for prostate cancer patients with advanced tumors that have spread to the bone, but a radioisotope procedure being evaluated in a clinical trial is extending lives by several months, according to a study presented at the Society of Nuclear Medicine (SNM) annual meeting, being held in Miami Beach, FL, this week.

June 10, 2012

GE, Affibody to develop PET imaging agent

By AuntMinnieEurope.com staff writers

GE Healthcare and Swedish biopharmaceutical company Affibody are collaborating on the development of a HER2-targeted PET imaging agent for patients with breast or gastric cancer.

June 4, 2012

Dilon promotes declipseSPECT study results

By AuntMinnieEurope.com staff writers

Breast-specific gamma imaging developer Dilon Diagnostics is highlighting clinical research regarding its declipseSPECT device presented in March at the Society of Surgical Oncology annual cancer symposium.

May 8, 2012

Previous Page

Page 64 of 90

Next Page